Readystate Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$703K Buy
+2,400
New +$789K 0.03% 481
2025
Q1
Sell
-16,800
Closed -$6.2M 639
2024
Q4
$6.2M Sell
16,800
-2,700
-14% -$1.13M 0.19% 116
2024
Q3
$10.1M Buy
19,500
+18,400
+1,673% +$9.83M 0.19% 231
2024
Q2
$596K Sell
1,100
-10,700
-91% -$5.66M 0.02% 470
2024
Q1
$6.12M Buy
+11,800
New +$5.87M 0.09% 328

Other funds holding ELV

Readystate Asset Management's ELV Position: Q1 2025 in Review

Readystate Asset Management sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 7,839 shares — an estimated $2.89M sold.

Readystate Asset Management first reported a position in ELV in Q3 2024 and held it in 2 quarters. The position peaked at $3.17M in Q3 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Readystate Asset Management reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Readystate Asset Management sold 7,839 Elevance Health shares in Q1 2025, an estimated $2.89M.
  • Readystate Asset Management first reported a position in Elevance Health in Q3 2024 and held it in 2 quarters.
  • Readystate Asset Management's Elevance Health position peaked at $3.17M in Q3 2024.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Readystate Asset Management's 13F filing for Q1 2025, filed 6 May 2025.